Skip to main content
. 2022 Feb 4;54(1):80–90. doi: 10.3947/ic.2021.0126

Table 5. Susceptibility of Staphylococcus strains to anti-MRSA drugs.

Drug MIC (µg/mL) MRSA Staphylococcus epidermidis Staphylococcus haemolyticus Staphylococcus hominis Total
Arbekacin <1 2 9 7 1 19
2 1 1
Vancomycin 1 2 1 1 4
2 9 4 1 14
4 2 2
Teicoplanin <2 2 4 1 1 8
4 4 2 6
8 2 2 4
>16 2 2
Linezolid <2 2 10 7 1 20

MIC, minimum inhibitory concentration; MRSA, methicillin-resistant Staphylococcus aureus.